|
Volumn 33, Issue 5, 2005, Pages 399-404
|
Rosiglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice
a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
APOLIPOPROTEIN E;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
ROSIGLITAZONE;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL;
AORTA;
ARTICLE;
ATHEROSCLEROSIS;
BIOSYNTHESIS;
BLOOD;
BODY WEIGHT;
DRUG EFFECT;
FEMALE;
GENETICS;
GLUCOSE BLOOD LEVEL;
MACROPHAGE;
MALE;
MOUSE;
MOUSE MUTANT;
PATHOLOGY;
PHYSIOLOGY;
ANIMALS;
AORTA;
APOLIPOPROTEINS E;
ATHEROSCLEROSIS;
BLOOD GLUCOSE;
BODY WEIGHT;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
FEMALE;
HYPOGLYCEMIC AGENTS;
MACROPHAGES;
MALE;
MICE;
MICE, KNOCKOUT;
THIAZOLIDINEDIONES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 33646195117
PISSN: 02533758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|